Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 274

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease

Open access
Zhu, Han, Cao, Chujin, Wu, Zhongcai, Zhang, Heping, Sun, Zhihong, Wang, Meng, Xu, Huzi, Zhao, Zhi, Wang, Yuxi, Pei, Guangchang, Yang, Qian, Zhu, Fengming, Yang, Juan, Deng, Xuan, Hong, Yu, Li, Yinzheng, Sun, Jie, Zhu, Fan, Shi, Mengxia, Qian, Kun, Ye, Ting, Zuo, Xuezhi, Zhao, Fenfei, Guo, Jing, Xu, Gang, Yao, Ying, Zeng, Rui·2021·Cell Metabolism

Abstract

The relationship between gut microbial dysbiosis and acute or chronic kidney disease (CKD) is still unclear. Here, we show that oral administration of the probiotic Lactobacillus casei Zhang (L. casei Zhang) corrected bilateral renal ischemia-reperfusion (I/R)-induced gut microbial dysbiosis, alleviated kidney injury, and delayed its progression to CKD in mice. L. casei Zhang elevated the levels of short-chain fatty acids (SCFAs) and nicotinamide in the serum and kidney, resulting in reduced renal inflammation and damage to renal tubular epithelial cells. We also performed a 1-year phase 1 placebo-controlled study of oral L. casei Zhang use (Chinese clinical trial registry, ChiCTR-INR-17013952), which was well tolerated and slowed the decline of kidney function in individuals with stage 3-5 CKD. These results show that oral administration of L. casei Zhang, by altering SCFAs and nicotinamide metabolism, is a potential therapy to mitigate kidney injury and slow the progression of renal decline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2021.06.014

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 274

Metadata

Authors
Zhu, H., Cao, C., Wu, Z., Zhang, H., Sun, Z., Wang, M., Xu, H., Zhao, Z., Wang, Y., Pei, G., Yang, Q., Zhu, F., Yang, J., Deng, X., Hong, Y., Li, Y., Sun, J., Zhu, F., Shi, M., Qian, K., Ye, T., Zuo, X., Zhao, F., Guo, J., Xu, G., Yao, Y., & Zeng, R.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2021-10
Volume
33
Issue
10
Pages
1926-1942.e8
ISSN
1550-4131 (ISSN-L)
OpenAlex
W3178750613
Cited by
274
References
52
FWCI
23.25
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease. https://app.cochat.ai/papers/10.1016/j.cmet.2021.06.014
The paper
Zhu, H., Cao, C., Wu, Z., Zhang, H., Sun, Z., Wang, M., Xu, H., Zhao, Z., Wang, Y., Pei, G., Yang, Q., Zhu, F., Yang, J., Deng, X., Hong, Y., Li, Y., Sun, J., Zhu, F., Shi, M., . . . Zeng, R. (2021). The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease. Cell Metabolism. https://doi.org/10.1016/j.cmet.2021.06.014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.